drugset / Trial / NCT03255512
Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is intended to investigate the pharmacodynamic drug-drug interaction as well as the safety and tolerability of isosorbite mononitrate and vericiguat in patients with stable coronary artery disease.
Timeline
- Start
- 2017-08-17
- Primary completion
- 2018-02-07
- Completion
- 2018-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isosorbide Mononitrate | Other / unclassified | 60 mg | — |
| Subject | Vericiguat | Other / unclassified | 10 mg | — |